ARROWHEAD PHARMACEUTICALS, INC. Increase (Decrease) in Contract with Customer, Liability
ARROWHEAD PHARMACEUTICALS, INC. (ARWR) reported Increase (Decrease) in Contract with Customer, Liability of $123.94 million for the 9-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInContractWithCustomerLiability · last filed 2026-08-04
- ARROWHEAD PHARMACEUTICALS, INC. increase (decrease) in contract with customer, liability for the quarter ending 2026-06-30 was -$30.82M.
- ARROWHEAD PHARMACEUTICALS, INC. increase (decrease) in contract with customer, liability for the quarter ending 2026-03-31 was -$8.60M, a 119.87% decline year-over-year.
- ARROWHEAD PHARMACEUTICALS, INC. increase (decrease) in contract with customer, liability for the quarter ending 2025-12-31 was $163.36M.
- ARROWHEAD PHARMACEUTICALS, INC. increase (decrease) in contract with customer, liability for the quarter ending 2025-09-30 was -$20.58M.
- ARROWHEAD PHARMACEUTICALS, INC. increase (decrease) in contract with customer, liability for fiscal 2025 was $2.40M.
- ARROWHEAD PHARMACEUTICALS, INC. increase (decrease) in contract with customer, liability for fiscal 2024 was -$866.00K.
- ARROWHEAD PHARMACEUTICALS, INC. increase (decrease) in contract with customer, liability for fiscal 2023 was -$129.18M.
- ARROWHEAD PHARMACEUTICALS, INC. increase (decrease) in contract with customer, liability for fiscal 2022 was -$112.50M, a 150.39% decline from fiscal 2021.
| Period end | Increase (Decrease) in Contract with Customer, Liability 3 month | Increase (Decrease) in Contract with Customer, Liability 3 month as first filed | Increase (Decrease) in Contract with Customer, Liability 6 month | Increase (Decrease) in Contract with Customer, Liability 6 month as first filed | Increase (Decrease) in Contract with Customer, Liability 9 month | Increase (Decrease) in Contract with Customer, Liability 9 month as first filed | Increase (Decrease) in Contract with Customer, Liability 12 month | Increase (Decrease) in Contract with Customer, Liability 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$30.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-04 | -$39.42M derived: sum of 2 quarters · filed 2026-08-04 | $123.94M 10-Q · filed 2026-08-04 | $103.36M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2026-03-31 | -$8.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-07 | $154.76M 10-Q · filed 2026-05-07 | $134.18M derived: sum of 3 quarters · filed 2026-05-07 | $113.89M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-12-31 | $163.36M 10-Q · filed 2026-02-05 | $142.78M derived: sum of 2 quarters · filed 2026-02-05 | $122.49M derived: sum of 3 quarters · filed 2026-08-04 | $165.76M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-09-30 | -$20.58M derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-25 | -$40.87M derived: sum of 2 quarters · filed 2026-08-04 | $2.40M derived: sum of 3 quarters · filed 2026-08-04 | $2.40M 10-K · filed 2025-11-25 | ||||
| 2025-06-30 | -$20.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-04 | $22.98M derived: sum of 2 quarters · filed 2026-08-04 | $22.98M 10-Q · filed 2026-08-04 | $22.98M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-03-31 | $43.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-07 | $43.27M 10-Q · filed 2026-05-07 | $43.27M derived: sum of 3 quarters · filed 2026-05-07 | $43.27M derived: sum of 4 quarters · filed 2026-05-07 | ||||
| 2024-12-31 | $0.00 10-Q · filed 2026-02-05 | $0.00 derived: sum of 2 quarters · filed 2026-02-05 | $0.00 derived: sum of 3 quarters · filed 2026-02-05 | $0.00 derived: sum of 4 quarters · filed 2026-02-05 | ||||
| 2024-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-25 | $0.00 derived: sum of 2 quarters · filed 2025-11-25 | $0.00 derived: sum of 3 quarters · filed 2025-11-25 | -$866.00K 10-K · filed 2025-11-25 | ||||
| 2024-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-08-07 | $0.00 derived: sum of 2 quarters · filed 2025-08-07 | -$866.00K 10-Q · filed 2025-08-07 | -$16.91M derived: sum of 4 quarters · filed 2025-11-25 | ||||
| 2024-03-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-05-12 | -$866.00K 10-Q · filed 2025-05-12 | -$16.91M derived: sum of 3 quarters · filed 2025-11-25 | -$30.91M derived: sum of 4 quarters · filed 2025-11-25 | ||||
| 2023-12-31 | -$866.00K 10-Q · filed 2025-02-10 | -$16.91M derived: sum of 2 quarters · filed 2025-11-25 | -$30.91M derived: sum of 3 quarters · filed 2025-11-25 | -$107.07M derived: sum of 4 quarters · filed 2025-11-25 | ||||
| 2023-09-30 | -$16.04M derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-25 | -$30.05M derived: sum of 2 quarters · filed 2025-11-25 | -$106.20M derived: sum of 3 quarters · filed 2025-11-25 | -$129.18M 10-K · filed 2025-11-25 | ||||
| 2023-06-30 | -$14.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-08-08 | -$90.17M derived: sum of 2 quarters · filed 2024-08-08 | -$113.14M 10-Q · filed 2024-08-08 | -$138.54M derived: sum of 4 quarters · filed 2024-11-26 | ||||
| 2023-03-31 | -$76.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-05-09 | -$99.14M 10-Q · filed 2024-05-09 | -$124.54M derived: sum of 3 quarters · filed 2024-11-26 | -$156.71M derived: sum of 4 quarters · filed 2024-11-26 | ||||
| 2022-12-31 | -$22.98M 10-Q · filed 2024-02-06 | -$48.38M derived: sum of 2 quarters · filed 2024-11-26 | -$80.55M derived: sum of 3 quarters · filed 2024-11-26 | -$108.04M derived: sum of 4 quarters · filed 2024-11-26 | ||||
| 2022-09-30 | -$25.40M derived: 10-K 12 month − 10-Q 9 month · filed 2024-11-26 | -$57.58M derived: sum of 2 quarters · filed 2024-11-26 | -$85.06M derived: sum of 3 quarters · filed 2024-11-26 | -$112.50M 10-K · filed 2024-11-26 | ||||
| 2022-06-30 | -$32.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-08-07 | -$59.66M derived: sum of 2 quarters · filed 2023-08-07 | -$87.10M 10-Q · filed 2023-08-07 | -$75.23M derived: sum of 4 quarters · filed 2023-11-29 | ||||
| 2022-03-31 | -$27.49M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-05-02 | -$54.93M 10-Q · filed 2023-05-02 | -$43.06M derived: sum of 3 quarters · filed 2023-11-29 | -$78.79M derived: sum of 4 quarters · filed 2023-11-29 | ||||
| 2021-12-31 | -$27.44M 10-Q · filed 2023-02-06 | -$15.57M derived: sum of 2 quarters · filed 2023-11-29 | -$51.30M derived: sum of 3 quarters · filed 2023-11-29 | $208.37M derived: sum of 4 quarters · filed 2023-11-29 | ||||
| 2021-09-30 | $11.87M derived: 10-K 12 month − 10-Q 9 month · filed 2023-11-29 | -$23.86M derived: sum of 2 quarters · filed 2023-11-29 | $235.81M derived: sum of 3 quarters · filed 2023-11-29 | $223.26M 10-K · filed 2023-11-29 | ||||
| 2021-06-30 | -$35.73M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-08-04 | $223.94M derived: sum of 2 quarters · filed 2022-08-04 | $211.39M 10-Q · filed 2022-08-04 | $204.41M derived: sum of 4 quarters · filed 2022-11-28 | ||||
| 2021-03-31 | $259.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-05-10 | $247.12M 10-Q · filed 2022-05-10 | $240.13M derived: sum of 3 quarters · filed 2022-11-28 | $233.23M derived: sum of 4 quarters · filed 2022-11-28 | ||||
| 2020-12-31 | -$12.55M 10-Q · filed 2022-02-02 | -$19.53M derived: sum of 2 quarters · filed 2022-11-28 | -$26.43M derived: sum of 3 quarters · filed 2022-11-28 | -$47.29M derived: sum of 4 quarters · filed 2022-11-28 | ||||
| 2020-09-30 | -$6.98M derived: 10-K 12 month − 10-Q 9 month · filed 2022-11-28 | -$13.88M derived: sum of 2 quarters · filed 2022-11-28 | -$34.74M derived: sum of 3 quarters · filed 2022-11-28 | -$63.51M 10-K · filed 2022-11-28 | -$63.51M 10-K · filed 2020-11-23 | |||
| 2020-06-30 | -$6.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-08-05 | -$27.76M derived: sum of 2 quarters · filed 2021-08-05 | -$56.53M 10-Q · filed 2021-08-05 | -$56.53M 10-Q · filed 2020-08-05 | -$71.67M derived: sum of 4 quarters · filed 2021-11-22 | |||
| 2020-03-31 | -$20.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-05-04 | -$49.63M 10-Q · filed 2021-05-04 | -$49.63M 10-Q · filed 2020-05-07 | -$64.77M derived: sum of 3 quarters · filed 2021-11-22 | -$87.45M derived: sum of 4 quarters · filed 2021-11-22 | |||
| 2019-12-31 | -$28.77M 10-Q · filed 2021-02-04 | -$28.77M 10-Q · filed 2020-02-05 | -$43.91M derived: sum of 2 quarters · filed 2021-11-22 | -$66.59M derived: sum of 3 quarters · filed 2021-11-22 | -$104.06M derived: sum of 4 quarters · filed 2021-11-22 | |||
| 2019-09-30 | -$15.14M derived: 10-K 12 month − 10-Q 9 month · filed 2021-11-22 | -$37.82M derived: sum of 2 quarters · filed 2021-11-22 | -$75.29M derived: sum of 3 quarters · filed 2021-11-22 | $82.80M 10-K · filed 2021-11-22 | $82.80M 10-K · filed 2019-11-25 | |||
| 2019-06-30 | -$22.68M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-08-05 | -$60.16M derived: sum of 2 quarters · filed 2020-08-05 | $97.94M 10-Q · filed 2020-08-05 | $97.00M derived: sum of 4 quarters · filed 2020-11-23 | ||||
| 2019-03-31 | -$37.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-05-07 | $120.62M 10-Q · filed 2020-05-07 | $119.68M derived: sum of 3 quarters · filed 2020-11-23 | $119.06M derived: sum of 4 quarters · filed 2020-11-23 | ||||
| 2018-12-31 | $158.10M 10-Q · filed 2020-02-05 | $157.15M derived: sum of 2 quarters · filed 2020-11-23 | $156.53M derived: sum of 3 quarters · filed 2020-11-23 | $156.22M derived: sum of 4 quarters · filed 2020-11-23 | ||||
| 2018-09-30 | -$942.60K derived: 10-K 12 month − 10-Q 9 month · filed 2020-11-23 | -$1.56M derived: sum of 2 quarters · filed 2020-11-23 | -$1.87M derived: sum of 3 quarters · filed 2020-11-23 | -$5.27M 10-K · filed 2020-11-23 | ||||
| 2018-06-30 | -$621.80K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-08-05 | -$931.80K derived: sum of 2 quarters · filed 2019-08-05 | -$4.33M 10-Q · filed 2019-08-05 | |||||
| 2018-03-31 | -$310.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-05-08 | -$3.70M 10-Q · filed 2019-05-08 | ||||||
| 2017-12-31 | -$3.39M 10-Q · filed 2019-02-07 | |||||||
| 2017-09-30 | $157.98K 10-K · filed 2019-11-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |